Belite Bio BLTE
NASDAQ BLTE
$166.66 +0.73 (+0.44%)
At close: Sep 29, 2026 · 4:00 PM EDT

Belite Bio (BLTE) Total Current Liabilities (2021 - 2026)

Updated

Belite Bio (BLTE) posted Total Current Liabilities of $14.95 million for Q2 2026, up 129.2% from $6.52 million a year earlier but down 3.5% from the prior quarter.

Analysis

Belite Bio (BLTE) Total Current Liabilities (2021 - 2026) Analysis & Trends

At the end of FY2025, Belite Bio's Total Current Liabilities came in at $10.07 million, up 66.4% from FY2024.

  • Annual Total Current Liabilities has increased for four consecutive years, with a four-year compound annual growth rate of 57.5% (FY2021 to FY2025).
  • In prior years, Belite Bio's Total Current Liabilities was $6.05 million in FY2024 (+66.5%), $3.63 million in FY2023 (+72.7%), $2.1 million in FY2022 (+28.7%) and $1.64 million in FY2021.
  • Quarterly Total Current Liabilities has run from a low of $1.43 million in Q2 2022 to a high of $15.48 million in Q1 2026 over five years.
  • On a year-over-year basis, Total Current Liabilities has increased in each of the last seven quarters, with growth averaging 76.7% over the last eight quarters.
  • The strongest year-over-year quarter for Total Current Liabilities in the past five years was Q2 2023, with growth of 249.1%; the weakest was Q3 2024, with a decline of 24.6%.
  • According to Business Quant data, Total Current Liabilities for the three prior quarters was $15.48 million (Q1 2026), $10.07 million (Q4 2025) and $8.07 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 54.90 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 41.64 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -31.55 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.94 Bn
10 Belite Bio 6.53 Bn 6.53 Bn - 14.95 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 14.95 Mn
Mar 31, 2026 15.48 Mn
Dec 31, 2025 10.07 Mn
Sep 30, 2025 8.07 Mn
Jun 30, 2025 6.52 Mn
Mar 31, 2025 6.13 Mn
Dec 31, 2024 6.05 Mn
Sep 30, 2024 3.62 Mn
Jun 30, 2024 3.84 Mn
Mar 31, 2024 4.68 Mn
Dec 31, 2023 3.63 Mn
Sep 30, 2023 4.80 Mn
Jun 30, 2023 4.98 Mn
Mar 31, 2023 4.65 Mn
Dec 31, 2022 2.10 Mn
Jun 30, 2022 1.43 Mn
Dec 31, 2021 1.64 Mn
API Access

Belite Bio Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=BLTE&period=max&api_key=YOUR_API_KEY